| RADNOR, Pa., Feb. 28, 2012 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing innovative therapeutic drugs to treat serious acute-care conditions, announced today that Nicholas Landekic, the Company's President & CEO will present at the Cowen and Company 32 nd Annual Health Care Conference on Tuesday, March 6 th at 8:40 a.m. Eastern Time. The conference is being held at the Boston Marriott Copley Place. A live webcast of Mr. Landekic's presentation...continued PYMX heparin antibiotics lovenox |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Pages
▼
No comments:
Post a Comment